Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2015 (2015), Article ID 576263, 4 pages
http://dx.doi.org/10.1155/2015/576263
Case Report

Resolution of Fundic Gland Polyposis following Laparoscopic Magnetic Sphincter Augmentation and Subsequent Cessation of Proton Pump Inhibitors

1Minimally Invasive Bariatric Surgery and Advanced Laparoscopy Fellowship, Gundersen Medical Foundation, 1900 South Avenue, La Crosse, WI 54601, USA
2Department of General and Vascular Surgery, Gundersen Health System, 1900 South Avenue, La Crosse, WI 54601, USA
3Department of Pathology, Gundersen Health System, 1900 South Avenue, La Crosse, WI 54601, USA

Received 16 July 2015; Accepted 11 October 2015

Academic Editor: Haruhiko Sugimura

Copyright © 2015 Joel R. Brockmeyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Ally, G. R. Veerappan, C. L. Maydonovitch et al., “Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps,” Digestive Diseases and Sciences, vol. 54, no. 12, pp. 2617–2622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Abraham, B. Nobukawa, F. M. Giardiello, S. R. Hamilton, and T. T. Wu, “Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the β-catenin gene,” American Journal of Pathology, vol. 158, no. 3, pp. 1005–1010, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. H. J. Freeman, “Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis,” World Journal of Gastroenterology, vol. 14, no. 9, pp. 1318–1320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Spiegel, P. Stein, M. Patel, R. Patel, and E. Lebovics, “A report of gastric fundic gland polyps,” Gastroenterology and Hepatology, vol. 6, no. 1, pp. 45–48, 2010. View at Google Scholar · View at Scopus
  5. J. R. Graham, “Gastric polyposis: onset during long-term therapy with omeprazole,” Medical Journal of Australia, vol. 157, no. 4, pp. 287–288, 1992. View at Google Scholar · View at Scopus
  6. M. Jalving, J. J. Koornstra, J. Wesseling, H. M. Boezen, S. De Jong, and J. H. Kleibeuker, “Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 9, pp. 1341–1348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Zelter, J. L. Fernández, C. Bilder et al., “Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies,” Digestive Diseases and Sciences, vol. 56, no. 6, pp. 1743–1748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Cats, B. Ed Schenk, E. Bloemena et al., “Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment,” Human Pathology, vol. 31, no. 6, pp. 684–690, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Nishi, H. Makuuchi, and W. M. Weinstein, “Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus,” Tokai Journal of Experimental and Clinical Medicine, vol. 30, no. 2, pp. 117–121, 2005. View at Google Scholar · View at Scopus
  10. M. Vieth and M. Stolte, “Fundic gland polyps are not induced by proton pump inhibitor therapy,” American Journal of Clinical Pathology, vol. 116, no. 5, pp. 716–720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. T. Wu, S. Kornacki, A. Rashid, J. H. Yardley, and S. R. Hamilton, “Dysplasia and dysregulation of proliferation in foveoral and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis,” American Journal of Surgical Pathology, vol. 22, no. 3, pp. 293–298, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. S. W. Carmack, R. M. Genta, C. M. Schuler, and M. H. Saboorian, “The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients,” The American Journal of Gastroenterology, vol. 104, no. 6, pp. 1524–1532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ueyama, T. Yao, Y. Nakashima et al., “Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma,” The American Journal of Surgical Pathology, vol. 34, no. 5, pp. 609–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Jain and R. Chetty, “Gastric hyperplastic polyps: a review,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1839–1846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. C. Abraham, V. K. Singh, J. H. Yardley, and T. T. Wu, “Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy,” American Journal of Surgical Pathology, vol. 25, no. 4, pp. 500–507, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Ming, “Malignant potential of gastric polyps,” Gastrointestinal Radiology, vol. 1, no. 1, pp. 121–125, 1976. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Lipham, P. A. Taiganides, B. E. Louie, R. A. Ganz, and T. R. Demeester, “Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease,” Diseases of the Esophagus, vol. 28, no. 4, pp. 305–311, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Ganz, J. H. Peters, S. Horgan et al., “Esophageal sphincter device for gastroesophageal reflux disease,” The New England Journal of Medicine, vol. 368, no. 8, pp. 719–727, 2013. View at Publisher · View at Google Scholar · View at Scopus